Enstilar Foam (Calcipotriol/Betamethasone)

Do’s

• Before starting to use Enstilar Foam, read the Patient Information Leaflet if available from your pharmacist. If you have any questions, ask your healthcare provider.
• Enstilar Foam is for use on the skin only. Apply a thin layer to the affected area(s) as directed by your healthcare provider, usually once daily. Rub it in gently and completely. 
• Wash your hands after use, unless you are using this medication to treat the hands. 
• Inform your healthcare provider if your condition does not improve or if it worsens. It may take a week to see any improvement and several weeks to see the full benefit of this medication.

Don’ts

• Avoid getting any medication in the eyes or mouth. If this occurs, rinse right away with water. 
• Do not apply this medication to the face, underarms, or groin area.
• Do not use Enstilar Foam for more than 4 weeks unless directed by your healthcare provider.
• Do not use more than 60 grams of the foam every 4 days.
• Do not bandage, wrap, or cover the treated area unless your healthcare provider instructs you to do so
• Do not apply this medication to large areas of damaged skin or use it in skin folds.
• Do not apply more of this medication than prescribed or use it more often or for longer than directed.

• Irritation
• Itching
• Inflamed hair pores (folliculitis)
• Changes in skin color
• Rash with raised red bumps or skin welts (hives)
• Worsening of psoriasis

These are not all the possible side effects of Enstilar Foam. If you experience any of these side effects, report them to your healthcare provider immediately. 

Avoid using Enstilar Foam if you have thinning of your skin (atrophy) at the treatment site. 

Enstilar Foam is flammable. Avoid fire, flame, and smoking when applying and right after you apply Enstilar Foam.

Pediatric patients are at greater risk of HPA axis suppression and adrenal insufficiency with the use of topical corticosteroids including Enstilar Foam. Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in pediatric patients treated with topical corticosteroids. Local adverse reactions including striae have been reported with the use of topical corticosteroids in pediatric patients.

Enstilar Foam is contraindicated in erythrodermic and pustular psoriasis. It is also contraindicated in patients with known disorders of calcium metabolism and in certain skin conditions such as viral, fungal, or bacterial skin infections, among others.

Pregnant and breastfeeding women should use Enstilar Foam on the smallest area of skin and for the shortest duration possible, and avoid applying it directly to the nipple and areola to avoid direct infant exposure.

Discuss all medical conditions with your healthcare provider before starting Enstilar Foam and follow the prescribed dosage and administration instructions.

For a full list of warnings and precautions, read the patient information leaflet provided in the pack before starting any course of treatment.